New insights into the biology of peritoneal mesothelial cells: The roles of epithelial-to-mesenchymal transition and cellular senescence

Nephron - Experimental Nephrology

Volumn 108, Issue 4, 2008, Pages

  Witowski, Janusz ^a,b   Ksia̧zek, Krzysztof ^a   Jörres, Achim ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Epithelial to mesenchymal transition; Mesothelial cells; Peritoneal dialysis; Senescence; Transforming growth factor 1; Vascular endothelial growth factor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYTOKERATIN; DOUBLE STRANDED DNA; FIBRONECTIN; GLUTATHIONE; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VASCULOTROPIN; ZINC FINGER PROTEIN;

CELL AGING; CELL FUNCTION; CYTOLOGY; CYTOSKELETON; DNA DAMAGE; ENDOTHELIUM CELL; EPITHELIUM; EXTRACELLULAR MATRIX; HUMAN; MESENCHYME; MESOTHELIUM CELL; MYOFIBROBLAST; NONHUMAN; OXIDATIVE STRESS; PERICYTE; PERITONEAL DIALYSIS; PERITONEUM CELL; PRIORITY JOURNAL; SHORT SURVEY; SMOOTH MUSCLE FIBER; TELOMERE; ULTRAFILTRATION;

ANIMALS; CELL AGING; CELL DIFFERENTIATION; EPITHELIAL CELLS; EPITHELIUM; HUMANS; MODELS, BIOLOGICAL; PERITONEUM;

EID: 43949098268     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000126920     Document Type: Short Survey

References (37)

1. Dobbie JW: New concepts in molecular biology and ultrastructural pathology of the peritoneum: their significance for peritoneal dialysis. Am J Kidney Dis 1990;15:97-109.
2. Herrick SE, Mutsaers SE: The potential of mesothelial cells in tissue engineering and regenerative medicine applications. Int J Artif Organs 2007;30:527-540.
3. Lopez-Cabrera M, Aguilera A, Aroeira LS, Ramirez-Huesca M, Perez-Lozano ML, Jimenez-Heffernan JA, Bajo MA, del Peso G, Sanchez-Tomero JA, Selgas R: Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure. Perit Dial Int 2006;26:26-34.
4. Mutsaers SE: The mesothelial cell. Int J Biochem Cell Biol 2004;36:9-16.
5. Mutsaers SE, Prele CM, Lansley SM, Herrick SE: The origin of regenerating mesothelium: a historical perspective. Int J Artif Organs 2007;30:484-494.
6. Raftery AT, Slater ND, Cope GH: Clinical anatomy of the peritoneal mesothelium: a review. Clin Anat 1989;2:69-85.
7. Yung S, Li FK, Chan TM: Peritoneal mesothelial cell culture and biology. Perit Dial Int 2006;26:162-173.
8. Krediet RT: Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int 2001;21:560-567.
9. Munoz-Chapuli R, Gonzalez-Iriarte M, Carmona R, Atencia G, Macias D, Perez-Pomares JM: Cellular precursors of the coronary arteries. Tex Heart Inst J 2002;29:243-249.
10. Wilm B, Ipenberg A, Hastie ND, Burch JB, Bader DM: The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature. Development 2005;132:5317-5328.
11. Kawaguchi M, Bader DM, Wilm B: Serosal mesothelium retains vasculogenic potential. Dev Dyn 2007;236:2973-2979.
12. Aroeira LS, Aguilera A, Sanchez-Tomero JA, Bajo MA, del Peso G, Jimenez-Heffernan JA, Selgas R, Lopez-Cabrera M: Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 2007;18:2004-2013.
13. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Heffernan JA, Aguilera A, Sanchez-Tomero JA, Bajo MA, Alvarez V, Castro MA, del Peso G, Cirujeda A, Gamallo C, Sanchez-Madrid F, Lopez-Cabrera M: Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003;348:403-413.
14. Jimenez-Heffernan JA, Aguilera A, Aroeira LS, Lara-Pezzi E, Bajo MA, del Peso G, Ramirez M, Gamallo C, Sanchez-Tomero JA, Alvarez V, Lopez-Cabrera M, Selgas R: Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis. Virchows Arch 2004;444:247-256.
15. Zavadil J, Bottinger EP: TGF-β and epithelial-to-mesenchymal transitions. Oncogene 2005;24:5764-5774.
16. Yang AH, Chen JY, Lin JK: Myofibroblastic conversion of mesothelial cells. Kidney Int 2003;63:1530-1539.
17. 1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol 2001;12:2029-2039.
18. 1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 2005;16:425-436.
19. De Vriese AS, Tilton RG, Mortier S, Lameire NH: Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia. Nephrol Dial Transplant 2006;21:2549-2555.
20. Vargha R, Endemann M, Kratochwill K, Riesenhuber A, Wick N, Krachler AM, Malaga-Dieguez L, Aufricht C: Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents. Nephrol Dial Transplant 2006;21:2943-2947.
21. Aroeira LS, Aguilera A, Selgas R, Ramirez-Huesca M, Perez-Lozano ML, Cirugeda A, Bajo MA, del Peso G, Sanchez-Tomero JA, Jimenez-Heffernan JA, Lopez-Cabrera M: Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 2005;46:938-948.
22. Campisi J, d'Adda di Fagagna F: Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007;8:729-740.
23. Ksia̧żek K, Piwocka K, Brzezinska A, Sikora E, Zabel M, Brȩborowicz A, Jörres A, Witowski J: Early loss of proliferative potential of human peritoneal mesothelial cells in culture: the role of p16INK4a-mediated premature senescence. J Appl Physiol 2006;100:988-995.
24. Ksia̧żek K, Passos JF, Olijslagers S, Saretzki G, Martin-Ruiz C, von Zglinicki T: Premature senescence of mesothelial cells is associated with non-telomeric DNA damage. Biochem Biophys Res Commun 2007;362:707-711.
25. Ksia̧żek K, Brȩborowicz A, Jörres A, Witowski J: Oxidative stress contributes to accelerated development of the senescent phenotype in human peritoneal mesothelial cells exposed to high glucose. Free Radic Biol Med 2007;42:636-641.
26. 1. Lab Invest 2007;87:345-356.
27. 1 a link? Exp Gerontol 2007;42:840-843.
28. Nevado J, Vallejo S, El Assar M, Peiro C, Sanchez-Ferrer CF, Rodriguez-Manas L: Changes in the human peritoneal mesothelial cells during aging. Kidney Int 2006;69:313-322.
29. Ksia̧żek K, Jörres A, Witowski J: Senescence induces a proangiogenic switch in human peritoneal mesothelial cells. Rejuv Res 2008; in press.
30. Gotloib L, Shostak A, Wajsbrot V, Kushnier R: High glucose induces a hypertrophic, senescent mesothelial cell phenotype after long in vivo exposure. Nephron 1999;82:164-173.
31. Shostak A, Wajsbrot V, Gotloib L: High glucose accelerates the life cycle of the in vivo exposed mesothelium. Kidney Int 2000;58:2044-2052.
32. Szeto CC, Lai KB, Chow KM, Szeto CY, Wong TY, Li PK: Differential effects of transforming growth factor-β on the synthesis of connective tissue growth factor and vascular endothelial growth factor by peritoneal mesothelial cell. Nephron Exp Nephrol 2005;99:e95-e104.
33. Mandl-Weber S, Cohen CD, Haslinger B, Kretzler M, Sitter T: Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int 2002;61:570-578.
34. Leung JC, Chan LY, Li FF, Tang SC, Chan KW, Chan TM, Lam MF, Wieslander A, Lai KN: Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF. Nephrol Dial Transplant 2005;20:1336-1349.
35. Gotloib L, Gotloib LC, Khrizman V: The use of peritoneal mesothelium as a potential source of adult stem cells. Int J Artif Organs 2007;30:501-512.
36. Siegel PM, Massague J: Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer 2003;3:807-821.
37. Szeto CC, Chow KM, Lai KB, Szeto CY, Kwan BC, Li PK: Connective tissue growth factor is responsible for transforming growth factor-β-induced peritoneal mesothelial cell apoptosis. Nephron Exp Nephrol 2006;103:e166-e174.